MiMedx Group, Inc. Accounts Receivable, Allowance for Credit Loss, Writeoff
MiMedx Group, Inc. (MDXG) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $16.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2026-07-29
- MiMedx Group, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2026-06-30 was $16.00K, a 94.31% decline year-over-year.
- MiMedx Group, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2026-03-31 was $629.00K.
- MiMedx Group, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-09-30 was $583.00K, a 161.43% increase year-over-year.
- MiMedx Group, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-06-30 was $281.00K, a 29.49% increase year-over-year.
- MiMedx Group, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2025 was $944.00K, a 55.52% increase from fiscal 2024.
- MiMedx Group, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2024 was $607.00K, a 70.93% decline from fiscal 2023.
- MiMedx Group, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2023 was $2.09M, a 832.14% increase from fiscal 2022.
- MiMedx Group, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2022 was $224.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 3 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 6 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 9 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.00K 10-Q · filed 2026-07-29 | $645.00K derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $629.00K 10-Q · filed 2026-07-29 | |||
| 2025-12-31 | $944.00K 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $583.00K 10-Q · filed 2025-10-29 | $864.00K derived: sum of 2 quarters · filed 2026-07-29 | $864.00K derived: sum of 3 quarters · filed 2026-07-29 | $953.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $281.00K 10-Q · filed 2026-07-29 | $281.00K derived: sum of 2 quarters · filed 2026-07-29 | $370.00K derived: sum of 3 quarters · filed 2026-07-29 | $593.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $0.00 10-Q · filed 2026-07-29 | $89.00K derived: sum of 2 quarters · filed 2026-07-29 | $312.00K derived: sum of 3 quarters · filed 2026-07-29 | $529.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2024-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $312.00K derived: sum of 2 quarters · filed 2026-02-25 | $529.00K derived: sum of 3 quarters · filed 2026-02-25 | $607.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $223.00K 10-Q · filed 2025-10-29 | $440.00K derived: sum of 2 quarters · filed 2025-10-29 | $518.00K 10-Q · filed 2024-10-30 | $659.00K derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-06-30 | $217.00K 10-Q · filed 2025-10-29 | $294.00K derived: sum of 2 quarters · filed 2025-10-29 | $436.00K derived: sum of 3 quarters · filed 2025-10-29 | $505.00K derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-03-31 | $77.00K 10-Q · filed 2025-10-29 | $219.00K derived: sum of 2 quarters · filed 2025-10-29 | $288.00K derived: sum of 3 quarters · filed 2025-10-29 | $2.04M derived: sum of 4 quarters · filed 2025-10-29 |
| 2023-12-31 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $211.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.97M derived: sum of 3 quarters · filed 2025-02-26 | $2.09M 10-K · filed 2025-02-26 |
| 2023-09-30 | $69.00K 10-Q · filed 2024-10-30 | $1.82M derived: sum of 2 quarters · filed 2024-10-30 | $1.95M 10-Q · filed 2024-10-30 | $2.00M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $1.75M 10-Q · filed 2024-07-31 | $1.88M 10-Q · filed 2023-08-01 | $1.93M derived: sum of 3 quarters · filed 2024-07-31 | $1.99M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | $122.00K 10-Q · filed 2024-07-31 | $172.00K derived: sum of 2 quarters · filed 2024-07-31 | $239.00K derived: sum of 3 quarters · filed 2024-07-31 | $322.00K derived: sum of 4 quarters · filed 2024-07-31 |
| 2022-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $117.00K derived: sum of 2 quarters · filed 2024-02-28 | $200.00K derived: sum of 3 quarters · filed 2024-02-28 | $224.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $67.00K 10-Q · filed 2023-10-30 | $150.00K derived: sum of 2 quarters · filed 2023-10-30 | $174.00K 10-Q · filed 2023-10-30 | |
| 2022-06-30 | $83.00K 10-Q · filed 2023-08-01 | $107.00K 10-Q · filed 2023-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |